代表卵巢癌微小残留病的3D微肿瘤对脂肪酸氧化抑制剂过己胺的反应（Adv. Healthcare Mater. 14/2025）

IF 10 2区医学 Q1 ENGINEERING, BIOMEDICAL

Advanced Healthcare Materials Pub Date : 2025-05-28 DOI:10.1002/adhm.202570082

Xingyun Yang, Mara Artibani, Yongcheng Jin, Aneesh Aggarwal, Yujia Zhang, Sandra Muñoz-Galvan, Ellina Mikhailova, Lena Rai, Nobina Mukherjee, Ravinash Krishna Kumar, Ashwag Albukhari, Shaohua Ma, Linna Zhou, Ahmed Ashour Ahmed, Hagan Bayley

{"title":"代表卵巢癌微小残留病的3D微肿瘤对脂肪酸氧化抑制剂过己胺的反应（Adv. Healthcare Mater. 14/2025）","authors":"Xingyun Yang, Mara Artibani, Yongcheng Jin, Aneesh Aggarwal, Yujia Zhang, Sandra Muñoz-Galvan, Ellina Mikhailova, Lena Rai, Nobina Mukherjee, Ravinash Krishna Kumar, Ashwag Albukhari, Shaohua Ma, Linna Zhou, Ahmed Ashour Ahmed, Hagan Bayley","doi":"10.1002/adhm.202570082","DOIUrl":null,"url":null,"abstract":"<p><b>Minimal Residual Disease</b></p><p>The cover image depicts 3D microtumors created with a microfluidic system. The microtumors retain key features of ovarian cancer minimal residual disease (MRD), a major cause of cancer recurrence. The in vitro model serves as a platform for testing therapeutics, and can support personalized treatment. More details can be found in article 2404072 by Linna Zhou, Ahmed Ashour Ahmed, Hagan Bayley, and co-workers.\n\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":"14 14","pages":""},"PeriodicalIF":10.0000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adhm.202570082","citationCount":"0","resultStr":"{\"title\":\"3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline (Adv. Healthcare Mater. 14/2025)\",\"authors\":\"Xingyun Yang, Mara Artibani, Yongcheng Jin, Aneesh Aggarwal, Yujia Zhang, Sandra Muñoz-Galvan, Ellina Mikhailova, Lena Rai, Nobina Mukherjee, Ravinash Krishna Kumar, Ashwag Albukhari, Shaohua Ma, Linna Zhou, Ahmed Ashour Ahmed, Hagan Bayley\",\"doi\":\"10.1002/adhm.202570082\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>Minimal Residual Disease</b></p><p>The cover image depicts 3D microtumors created with a microfluidic system. The microtumors retain key features of ovarian cancer minimal residual disease (MRD), a major cause of cancer recurrence. The in vitro model serves as a platform for testing therapeutics, and can support personalized treatment. More details can be found in article 2404072 by Linna Zhou, Ahmed Ashour Ahmed, Hagan Bayley, and co-workers.\\n\\n <figure>\\n <div><picture>\\n <source></source></picture><p></p>\\n </div>\\n </figure></p>\",\"PeriodicalId\":113,\"journal\":{\"name\":\"Advanced Healthcare Materials\",\"volume\":\"14 14\",\"pages\":\"\"},\"PeriodicalIF\":10.0000,\"publicationDate\":\"2025-05-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adhm.202570082\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advanced Healthcare Materials\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/adhm.202570082\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Healthcare Materials","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adhm.202570082","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}

引用次数: 0

摘要

最小残留疾病封面图像描绘了用微流体系统创建的3D微肿瘤。微肿瘤保留了卵巢癌微小残留病（MRD）的主要特征，这是癌症复发的主要原因。体外模型作为测试治疗方法的平台，可以支持个性化治疗。更多细节可以在Linna Zhou， Ahmed Ashour Ahmed， Hagan Bayley及其同事的文章2404072中找到。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline (Adv. Healthcare Mater. 14/2025)

Minimal Residual Disease

The cover image depicts 3D microtumors created with a microfluidic system. The microtumors retain key features of ovarian cancer minimal residual disease (MRD), a major cause of cancer recurrence. The in vitro model serves as a platform for testing therapeutics, and can support personalized treatment. More details can be found in article 2404072 by Linna Zhou, Ahmed Ashour Ahmed, Hagan Bayley, and co-workers.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Advanced Healthcare Materials 工程技术-生物材料

CiteScore

14.40

自引率

3.00%

发文量

600

审稿时长

1.8 months

期刊介绍： Advanced Healthcare Materials, a distinguished member of the esteemed Advanced portfolio, has been dedicated to disseminating cutting-edge research on materials, devices, and technologies for enhancing human well-being for over ten years. As a comprehensive journal, it encompasses a wide range of disciplines such as biomaterials, biointerfaces, nanomedicine and nanotechnology, tissue engineering, and regenerative medicine.